Synthesis and biological evaluation of Trifluoromethoxyphenyl Indole Carboxamide analogs, ADME and toxicity prediction

Authors

  • Baban Mohan Mulik Sharda University
  • Noopur Srivastava Sharda University
  • Dhananjay Pendharkar Integral Biosciences Pvt Ltd, Noida

DOI:

https://doi.org/10.62110/sciencein.cbl.2024.v11.660

Keywords:

Anticancer, Molecular docking study, Leukemia, Indole Carboxamide, heterocyclic drugs

Abstract

We report synthesis, ADME profile, and biological evaluation of new analogues as effective Anticancer Agents. Trifluoromethoxyphenyl indole-5-carboxamide analogues (4a-4m) were developed as a class of strong inhibitors of BCR-ABL1 kinase. The compounds (4c, 4e, and 4m) showed good anticancer activity in cancer cell lines such as MCF7, MV411 and K562 with IC50 values of 1.4 µM, 1.7 µM, and 1.1 µM, respectively. In human liver microsomes, these substances likewise displayed a favorable ADME profile, good solubility, and minimal clearance. In an oncology program these analogues offer a promising beginning for the development of BCR-ABL1 kinase inhibitors.

URN:NBN:sciencein.cbl.2024.v11.660 

Author Biographies

  • Baban Mohan Mulik, Sharda University

    Department of Chemistry and Biochemistry

  • Noopur Srivastava, Sharda University

    Department of Chemistry and Biochemistry, Sharda School of Basic Sciences & Research (SSBSR)

Indole Carboxamide anticancer drugs

Downloads

Published

2024-02-23

Issue

Section

Articles

URN

How to Cite

Synthesis and biological evaluation of Trifluoromethoxyphenyl Indole Carboxamide analogs, ADME and toxicity prediction. (2024). Chemical Biology Letters, 11(2), 660. https://doi.org/10.62110/sciencein.cbl.2024.v11.660

Similar Articles

1-10 of 114

You may also start an advanced similarity search for this article.